Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion

<div>Scoring criteria for IHC. (a) Cores were scored as having negative (0%), very low (1-5%), low (5-20%), moderate (20-50%), or high (&gt;50%) expression. (b) Squares represent areas where staining was assessed in each core. (c) Example of positive control tissue (liver).</div>

BioMed Research International

fig1

Figure 1

Figure 1: Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion 

Figure 1 | Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion 